Skip to main content
. 2020;20(1):4–11.

Table 1.

Baseline characteristics. Data are median (25th/75th centiles) or n (%). Bold type indicates significant p value.

Variable Intervention Placebo p value
Age (years) 4.9(4.4,5.2) 5.1(4.5,5.4) 0.318
Gender (female) 7(58%) 8(42%) 0.295
Ethnicity (caucasian) 12(100%) 14(74%) 0.21
Height (cms) 107.5(102.5, 113.4) 108.1 (103.8, 114) 0.43
Weight (kg) 18.3 (16.9, 21.7) 17.8 (16.2, 18.8) 0.68
BMI (kg/m2) 16.1 (15.7, 17.0) 15.0 (14.1, 16.2) 0.16
Serum 25OHD (nmol/l) 71(58,98) 79(61,81) 0.537
Serum calcium (mmol/l) 2.4(2.37,2.42) 2.35(2.31,2.42) 0.615
Serum phosphate (mmol/l) 1.52(1.5,1.62) 1.61(1.55,1.69) 0.058
Serum alkaline Phosphatase (u/l) 204.5(180,215) 200(186,213) 0.864
Serum albumin (g/l) 42(41,44) 42(41.5,43.5) 0.634
Serum magnesium (mmol/l) 0.85(0.85,0.89) 0.84(0.82,0.88) 0.379
Serum parathyroid hormone (ng/l) 27.9(24.0,34.1) 36.5(22.3,40.0) 0.685
Serum P1NP (ng/ml) 552.2(512.3,678.6) 587.1(518.2,801.7) 0.558
Serum CTX (ng/ml) 1.52(1.3,1.81) 1.59(1.3,1.81) 0.618
Dietary calcium intake (gms/day) 783(577,842) 521(430,535) 0.040
Activity score (METS units) 66 (44,83) 104 (68,120) 0.040